Clinical TrialsSearch results
Number of results: 208
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-P05: A Multi-Center Phase II Study in Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL)
- Acute promyelocytic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2007-03-19
Other
- Japan Diabetes Outcome Intervention Trial 1(J-DOIT1) : Intervention study to prevent or delay type 2 diabetes mellitus
- Impaired Fasting Glucose
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2007-03-30
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- Hypothyroidism in Hyperlipidemia in Japan
- Hyperlipidemia
- National Hospital Organization, Kyoto Medical Center
- 2007-04-01
Other
- Cyclosporin A (Neoral) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) requiring repetitive administration of high-dose intravenous immunoglobulin
- Chronic inflammatory demyelinating polyradiculoneuropathy
- CIDP Study Group
- 2007-04-10
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04